Index of reports
> Cases with Pyrexia (112)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prednisone where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 112 Next >>
Possible Prednisone side effects in female
Reported by a individual with unspecified qualification from United States on 2012-08-23
Patient: female, weighing 81.8 kg (180.0 pounds)
Reactions: Dyspnoea, Chest Pain, Pancytopenia, Pyrexia, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1400 mg
Doxorubicin Hydrochloride
Dosage: 94 mg
Prednisone
Dosage: 375 mg
Rituximab (Moab C2b8 Anti Cd20, Chimeric)
Dosage: 700 mg
Vincristine Sulfate
Dosage: 2 mg
Possible Prednisone side effects in male
Reported by a physician from United States on 2012-08-22
Patient: male, weighing 94.0 kg (206.8 pounds)
Reactions: Tachycardia, Clostridium Difficile Colitis, Pancytopenia, Neutropenia, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 2780 mg
Doxorubicin Hydrochloride
Dosage: 152 mg
Etoposide
Dosage: 720 mg
Fluorine-18 2-Fluorou-2 Deoxyry-D-Glucose (18f-Fdg)
Dosage: 12 mg
Prednisone
Dosage: 1300 mg
Rituximab
Dosage: 800 mg
Vincristine Sulfate
Dosage: 3.6 mg
Possible Prednisone side effects in male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-20
Patient: male
Reactions: Central Nervous System Lymphoma, Pyrexia, Thrombocytopenia, Cerebral Toxoplasmosis, Asthenia, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Istodax
Start date: 2012-03-27
Istodax
Istodax
Start date: 2012-05-30
End date: 2012-05-30
Prednisone
Dosage: 25 milligram
Administration route: Oral
Prednisone
Dosage: 50 milligram
Other drugs received by patient: Levothyroxine Sodium; Prednisone TAB; Omeprazole; Kytril
Possible Prednisone side effects in 41 year old female
Reported by a physician from United States on 2012-08-07
Patient: 41 year old female
Reactions: Night Sweats, Chills, Intestinal Mass, Pyrexia, Hypoaesthesia, Appendicitis, Postoperative Wound Infection, Alopecia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Humira
Start date: 2012-07-06
End date: 2012-07-06
Humira
Indication: Crohn's Disease
Start date: 2012-06-08
End date: 2012-06-08
Humira
Start date: 2012-06-22
End date: 2012-06-22
Humira
Indication: Crohn's Disease
Start date: 2012-07-06
Prednisone
Indication: Crohn's Disease
End date: 2012-06-01
Other drugs received by patient: Hydrocodone Bitartrate; Tylenol
Possible Prednisone side effects in 46 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30
Patient: 46 year old female
Reactions: Pain in Extremity, Anaemia, Pyrexia, Pallor, Stem Cell Transplant, Pulmonary Haemorrhage, Zygomycosis, Skin Discolouration, Blood Culture Positive, Diarrhoea Haemorrhagic, Small Intestinal Haemorrhage, Asthenia, Hepatosplenomegaly, Candidiasis, Cough
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Carmustine
Cyclophosphamide
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Cytarabine
Cytarabine
Dosage: 1.5 g/d/m2 (1 cycle)
Doxorubicin Hydrochloride
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Etoposide
Idarubicin HCL
Dosage: 12 mg/d/m2 (1 cycle)
Melphalan Hydrochloride
Oncovin
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Vorinostat
Dosage: 1 cycle
Administration route: Oral
Possible Prednisone side effects in 46 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27
Patient: 46 year old female
Reactions: Pancreatic Infarction, Unresponsive To Stimuli, Myelodysplastic Syndrome, Pyrexia, Pallor, Cerebral Haemorrhage, Skin Discolouration, Diarrhoea Haemorrhagic, Small Intestinal Haemorrhage, Apnoea, Thrombocytopenia, Cough, Candidiasis, Hepatosplenomegaly, Dyspnoea, Pain in Extremity, Anaemia, Pulmonary Haemorrhage, Zygomycosis, Diarrhoea, Hemisensory Neglect, Lung Infiltration, Asthenia, Hepatic Infarction
Adverse event resulted in: death
Drug(s) suspected as cause:
Carmustine
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Cytarabine
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Etoposide
Indication: Diffuse Large B-Cell Lymphoma
Idarubicin HCL
Dosage: 12 mg/m2, unk
Indication: Myelodysplastic Syndrome
Oncovin
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Suberoylanilide Hydroxamic Acid
Dosage: 500 mg, tid
Administration route: Oral
Indication: Myelodysplastic Syndrome
Other drugs received by patient: Radiotherapy
Possible Prednisone side effects in female
Reported by a physician from United States on 2012-07-27
Patient: female, weighing 54.1 kg (119.0 pounds)
Reactions: Pneumonia Primary Atypical, Diarrhoea, Hypotension, Cytomegalovirus Viraemia, Pyrexia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Certican
Dosage: 1.5 mg, bid
Administration route: Oral
Start date: 2011-02-03
End date: 2011-09-09
Certican
Dosage: 0.75 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-01-28
End date: 2011-02-02
Certican
Dosage: 0.75 mg, bid
Administration route: Oral
Start date: 2011-09-10
Leflunomide
Mycophenolate Mofetil
Dosage: 250 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2012-01-24
End date: 2012-01-29
Prednisone
Indication: Immunosuppression
Prednisone
Dosage: 2.5 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-01-28
Prograf
Dosage: 01 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-01-28
Prograf
Indication: Immunosuppression
Valcyte
Dosage: 450 mg, bid
Administration route: Oral
Indication: Cytomegalovirus Viraemia
Start date: 2011-08-25
Other drugs received by patient: Lasix
Possible Prednisone side effects in female
Reported by a physician from United States on 2012-07-26
Patient: female, weighing 50.6 kg (111.3 pounds)
Reactions: Nausea, Urinary Tract Infection, Cytomegalovirus Viraemia, Rhinorrhoea, Pyrexia, Renal Failure, Diarrhoea, Urosepsis, Neutropenia, Sinusitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bactrim
Indication: Prophylaxis
Mycophenolate Mofetil
Dosage: unk
Administration route: Oral
Start date: 2011-05-16
End date: 2011-06-04
Mycophenolate Mofetil
Dosage: 1000 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-08-24
End date: 2011-05-16
Prednisone
Dosage: 5 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-10-23
Prograf
Dosage: 4 mg am, 5 mg pm
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-12-09
End date: 2011-05-16
Prograf
Dosage: 2 mg, bid
Administration route: Oral
Start date: 2011-05-16
Other drugs received by patient: Losartan Potassium; Lasix
Possible Prednisone side effects in female
Reported by a physician from United States on 2012-07-24
Patient: female, weighing 51.4 kg (113.1 pounds)
Reactions: Nausea, Urinary Tract Infection, Rhinorrhoea, Cytomegalovirus Viraemia, Pyrexia, Renal Failure, Diarrhoea, Urosepsis, Neutropenia, Sinusitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bactrim
Indication: Prophylaxis
Mycophenolate Mofetil
Dosage: 1000 mg, bid
Administration route: Oral
End date: 2011-05-16
Mycophenolate Mofetil
Dosage: 1000 mg, bid
Administration route: Oral
Start date: 2011-05-16
End date: 2011-06-04
Mycophenolate Mofetil
Dosage: 1000 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-08-24
End date: 2011-05-04
Prednisone
Dosage: 5 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-10-23
Prograf
Dosage: 4 mg am, 5 mg pm
Administration route: Oral
End date: 2011-05-16
Prograf
Dosage: 2 mg, bid
Administration route: Oral
Start date: 2011-05-24
Prograf
Dosage: 4 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-12-09
Prograf
Dosage: unk
Administration route: Oral
Start date: 2011-05-16
Other drugs received by patient: Losartan Potassium; Lasix
Possible Prednisone side effects in 66 year old female
Reported by a physician from United States on 2012-07-23
Patient: 66 year old female, weighing 65.3 kg (143.7 pounds)
Reactions: Foot Deformity, Back Pain, Pelvic Fracture, Localised Infection, Pneumonia, Laceration, Blood Potassium Increased, Blood Magnesium Decreased, Pyrexia, Cystitis, Fall, Respiratory Tract Congestion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Enbrel
Dosage: 50 mg, qwk
Indication: Rheumatoid Arthritis
Start date: 2002-12-01
End date: 2012-06-01
Enbrel
Dosage: 50 mg, qwk
Indication: Osteoporosis
Start date: 2000-05-22
Prednisone
Dosage: unk
Possible Prednisone side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23
Patient: male, weighing 86.2 kg (189.6 pounds)
Reactions: Weight Decreased, Drug Dose Omission, Vomiting, Crohn's Disease, Chills, Decreased Activity, Pain, Pyrexia, Hyperhidrosis, Loss of Consciousness, Malaise, Hyperphagia, Diarrhoea
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisone
Indication: Crohn's Disease
Start date: 2012-01-01
Remicade
Indication: Crohn's Disease
Start date: 2010-01-01
End date: 2011-11-01
Remicade
Start date: 2012-01-01
End date: 2012-04-01
Possible Prednisone side effects in female
Reported by a physician from United States on 2012-07-18
Patient: female, weighing 59.1 kg (130.0 pounds)
Reactions: Abdominal Pain, Dehydration, Pancytopenia, Pyrexia, Neutropenia, Asthenia, Ascites
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1250 mg
Doxorubicin Hydrochloride
Dosage: 84 mg
Prednisone
Dosage: 200 mg
Rituximab (Moab C2b8 Anti Cd20, Chimeric)
Dosage: 620 mg
Vincristine Sulfate
Dosage: 2 mg
Possible Prednisone side effects in female
Reported by a consumer/non-health professional from Germany on 2012-07-06
Patient: female, weighing 70.0 kg (154.0 pounds)
Reactions: B-Cell Lymphoma, Anaemia, Urinary Incontinence, Abnormal Behaviour, Pulmonary Embolism, Cognitive Disorder, Pyrexia, Fall, Peripheral Sensory Neuropathy, Post Transplant Lymphoproliferative Disorder, Klebsiella Infection, Cytokine Release Syndrome, Cytomegalovirus Infection, Neutrophil Toxic Granulation Present, Traumatic Haematoma, Deep Vein Thrombosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, bid
Start date: 2009-07-23
Campath
Dosage: 20 mg, qd
Start date: 2009-07-07
Campath
Dosage: 30 mg, qd
Start date: 2009-08-06
End date: 2009-08-06
Campath
Dosage: 30 mg, qd
Start date: 2009-09-11
End date: 2009-10-22
Campath
Dosage: 10 mg, qd
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-23
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-07-23
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-08-20
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-07-21
Cyclophosphamide
Dosage: 1250 mg, once
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-23
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-09-08
End date: 2009-09-08
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-07-07
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-08-06
End date: 2009-08-20
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-07-07
Doxorubicin HCL
Dosage: 80 mg, once
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-23
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-07-21
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-08-06
End date: 2009-08-20
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-09-08
End date: 2009-09-08
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-07-23
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-08-20
Filgrastim
Dosage: 3000 iu, unk
Start date: 2009-07-26
End date: 2009-08-27
Filgrastim
Dosage: unk on days 4 through 13 of course 5
Start date: 2009-08-20
Filgrastim
Dosage: unk on days 4 through 12 of course 6
Start date: 2009-09-08
Filgrastim
Dosage: unk on days 4, 5, 6 of course 1
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-23
Filgrastim
Dosage: unk on days 4 through 15 of course 2
Start date: 2009-07-07
Filgrastim
Dosage: unk on days 4 through 8 and day 13 of course 3
Start date: 2009-07-23
Filgrastim
Dosage: unk on days 6 + 7 and days 9 through 12 of course 4
Start date: 2009-08-06
Filgrastim
Dosage: 30000 iu, qd
Start date: 2009-09-11
End date: 2009-09-19
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Start date: 2009-06-23
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Start date: 2009-09-11
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Start date: 2009-07-07
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-15
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Start date: 2009-08-06
End date: 2009-08-10
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Start date: 2009-07-23
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Start date: 2009-09-08
End date: 2009-09-08
Vincristine
Dosage: 2 mg, once
Start date: 2009-06-23
Vincristine
Dosage: 1 mg, once
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-15
Vincristine
Dosage: 2 mg, once
Start date: 2009-08-20
Vincristine
Dosage: 2 mg, once
Start date: 2009-07-23
Vincristine
Dosage: 2 mg, once
Start date: 2009-07-07
Vincristine
Dosage: 2 mg, once
Start date: 2009-07-21
Vincristine
Vincristine
Dosage: 2 mg, once
Start date: 2009-08-06
End date: 2009-08-20
Other drugs received by patient: Enoxaparin Sodium; Enoxaparin Sodium; Ganciclovir; Metoprolol Tartrate; Trimethoprim + Sulfamethoxazole; Dexamethasone; Antibiotics; Torsemide; Fluticasone Propionate W; Fondaparinux Sodium; Pantoprazole; Ganciclovir; Spiriva
Possible Prednisone side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29
Patient: male, weighing 98.9 kg (217.6 pounds)
Reactions: Liver Function Test Abnormal, Pyrexia, Leukocytosis, Cough
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisone
Dosage: 5 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-14
End date: 2011-10-15
Thymoglobulin
Dosage: unk
Indication: Transplant Rejection
Start date: 2011-10-04
End date: 2011-10-12
Other drugs received by patient: Valcyte; Albuterol; Bactrim; Pepcid; Tacrolimus; Vitamin D; Doxazosin Mesylate; Amlodipine; Metoprolol Succinate; Cellcept; Cefepime; Docusate; Nystatin; Famotidine; Fluticasone Propionate
Possible Prednisone side effects in male
Reported by a physician from Netherlands on 2012-06-25
Patient: male
Reactions: Urinary Tract Infection, Dysuria, Pollakiuria, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Certican
Dosage: unk
Indication: Renal Transplant
Start date: 2008-02-22
Neoral
Dosage: unk
Administration route: Oral
Indication: Renal Transplant
Start date: 2008-02-22
Prednisone
Possible Prednisone side effects in female
Reported by a physician from Japan on 2012-06-19
Patient: female
Reactions: Pain, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Acarbose
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Actemra
Start date: 2010-05-06
Actemra
Indication: Rheumatoid Arthritis
Start date: 2009-02-10
End date: 2010-03-09
Aspirin
Administration route: Oral
Indication: Prophylaxis
Azosemide
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Celecoxib
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Clopidogrel Bisulfate
Administration route: Oral
Indication: Prophylaxis
Glimepiride
Administration route: Oral
Indication: Diabetes Mellitus
Prednisolone
Administration route: Oral
Start date: 2009-04-07
Prednisone
Administration route: Oral
Prednisone
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2009-01-01
End date: 2009-04-06
Rabeprazole Sodium
Administration route: Oral
Indication: Gastrooesophageal Reflux Disease
Rebamipide
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Thyroid TAB
Administration route: Oral
Indication: Hypothyroidism
Other drugs received by patient: Pamilcon; Incremin (Japan); Trichlormethiazide; Norvasc; Naboal
Possible Prednisone side effects in female
Reported by a consumer/non-health professional from United States on 2012-06-19
Patient: female
Reactions: Pyrexia, Wound Secretion, Cartilage Atrophy, Feeling Cold, Tendon Injury, Tendon Pain, Fatigue, Joint Crepitation, Arthropathy, Fracture, Oedema Peripheral, Bacterial Infection, Joint Effusion, Hypersomnia, Musculoskeletal Pain, Osteopenia, Cartilage Injury, Radiation Associated Pain, Osteoarthritis, Osteosclerosis, Chondromalacia, Arthralgia, Joint Swelling, Tendon Disorder, Asthenia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Ciprofloxacin HCL
Dosage: unk
Indication: Post Procedural Infection
Start date: 2010-09-01
Prednisone
Dosage: unk
Indication: Pain
Start date: 2010-09-01
End date: 2010-12-29
Prednisone
Dosage: 10 mg, qd
Indication: Oedema Peripheral
Start date: 2011-02-01
End date: 2011-11-01
Other drugs received by patient: Vancomycin; Zanaflex; Cholecalciferol; Zosyn; Trimethoprim + Sulfamethoxazole
Possible Prednisone side effects in 71 year old male
Reported by a individual with unspecified qualification from United Kingdom on 2012-06-15
Patient: 71 year old male, weighing 79.7 kg (175.3 pounds)
Reactions: Haemoglobin Decreased, Chest Pain, Platelet Count Decreased, Pyrexia, Troponin Increased, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-25
Gemcitabine
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-04-01
Neulasta
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-04-02
Prednisone
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-29
Rituximab
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-25
Vincristine Sulfate
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-25
Other drugs received by patient: Metoclopramide; Cotrim; Tramadol HCL
Possible Prednisone side effects in 69 year old male
Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-06-05
Patient: 69 year old male
Reactions: Productive Cough, Dyspnoea, Hypotension, Pyrexia, Interstitial Lung Disease, Septic Shock, White Blood Cell Count Increased, Cough, Leukopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Indication: Prophylaxis
Prednisone
Indication: Premedication
Taxotere
Dosage: over 1 hour
Indication: Prostate Cancer
Taxotere
Dosage: over 1 hour
Taxotere
Dosage: cumulative dosage in 3rd cycle: 350 mg
Other drugs received by patient: Estramustine
Possible Prednisone side effects in male
Reported by a physician from United States on 2012-05-31
Patient: male, weighing 85.9 kg (189.0 pounds)
Reactions: Atelectasis, Pleural Effusion, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1500 mg
Doxorubicin Hydrochloride
Dosage: 80 mg
Etoposide
Dosage: 400 mg
Prednisone
Dosage: 1200 mg
Rituximab (Moab C2b8 Anti Cd20, Chimeric)
Dosage: 750 mg
Vincristine Sulfate
Dosage: 7.2 mg
Possible Prednisone side effects in 59 year old female
Reported by a physician from United States on 2012-05-24
Patient: 59 year old female
Reactions: Pneumonia, Drug Effect Decreased, Chills, Blood Triglycerides Increased, Psoriasis, Pyrexia, Chronic Obstructive Pulmonary Disease, Respiratory Tract Congestion, Basal Cell Carcinoma, Pulmonary Oedema, Sleep Apnoea Syndrome, Blood Glucose Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Humira
Indication: Psoriasis
Start date: 2011-05-10
End date: 2012-04-03
Prednisone
Indication: Pneumonia
Start date: 2012-04-01
Other drugs received by patient: Simvastatin; Lisinopril; Depakote; Restoril; Pravastatin; Geodon; Diltiazem; Seroquel; Acyclovir
Possible Prednisone side effects in
Reported by a physician from United States on 2012-05-18
Patient:
Reactions: Pancytopenia, Pyrexia, Haematoma
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Melphalan Hydrochloride
Dosage: 6 mg/m2, cyclic
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-04-19
End date: 2011-11-09
Prednisone
Dosage: 80 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-04-19
End date: 2011-11-09
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Multiple Myeloma
Start date: 2011-04-19
End date: 2011-11-09
Other drugs received by patient: Iron; Hyperium / 00939801 /; Nicardipine HCL; Vitamin D; Aranesp
Possible Prednisone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-18
Patient:
Reactions: Urticaria, Headache, Pyrexia, Oropharyngeal Pain, Constipation, Polyneuropathy, Fatigue, Dyspepsia, Oedema Peripheral, Cough, Dyspnoea, Vomiting, Nausea, Rash, Dysgeusia, Diarrhoea, Alopecia, Neutropenia, Respiratory Tract Infection, Leukopenia, Infection, Infusion Related Reaction
Drug(s) suspected as cause:
Cyclophosphamide
Indication: B-Cell Lymphoma
Doxorubicin HCL
Indication: B-Cell Lymphoma
Ofatumumab
Indication: B-Cell Lymphoma
Ofatumumab
Prednisone
Administration route: Oral
Indication: B-Cell Lymphoma
Vincristine
Indication: B-Cell Lymphoma
Other drugs received by patient: Cetirizine; Acetaminophen; Glucocorticoids
Possible Prednisone side effects in 27 year old female
Reported by a physician from Switzerland on 2012-05-18
Patient: 27 year old female, weighing 67.0 kg (147.4 pounds)
Reactions: Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Humira
Indication: Crohn's Disease
Start date: 2012-03-15
End date: 2012-03-15
Humira
Humira
Prednisone
Administration route: Oral
Prednisone
Administration route: Oral
Indication: Crohn's Disease
Start date: 2012-03-15
Other drugs received by patient: Solevita Forte; Belara
Possible Prednisone side effects in female
Reported by a individual with unspecified qualification from United States on 2012-05-08
Patient: female, weighing 40.5 kg (89.1 pounds)
Reactions: Vomiting, Dyspnoea, Chest Discomfort, Lactobacillus Infection, Nausea, Device Related Infection, Pyrexia, Diarrhoea, Staphylococcal Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1028 mg
Doxil
Dosage: 55 mg
Prednisone
Dosage: 500 mg
Rituximab (Moab C2b8 Anti Cd20, Chimeric)
Dosage: 514 mg
Vincristine Sulfate
Dosage: 1.9 mg
Possible Prednisone side effects in 77 year old female
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-05-07
Patient: 77 year old female
Reactions: Nausea, Subcutaneous Abscess, Disseminated Cryptococcosis, Encephalitis, Pyrexia, Headache, Somnolence, Viith Nerve Paralysis, Cryptococcosis, Syncope, Cryptococcal Fungaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisone
Possible Prednisone side effects in 61 year old male
Reported by a consumer/non-health professional from Germany on 2012-05-07
Patient: 61 year old male
Reactions: Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Belatacept
Indication: Renal Transplant
Start date: 2007-01-26
Mycophenolate Mofetil (Cellcept)
Start date: 2008-08-13
Prednisone
Start date: 2007-08-30
Other drugs received by patient: Allopurinol
Possible Prednisone side effects in 63 year old male
Reported by a individual with unspecified qualification from Germany on 2012-05-04
Patient: 63 year old male
Reactions: Dehydration, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Doxorubicin HCL
Indication: non-Hodgkin's Lymphoma
Mabthera
Indication: non-Hodgkin's Lymphoma
Prednisone
Indication: non-Hodgkin's Lymphoma
Vincristine
Indication: non-Hodgkin's Lymphoma
Possible Prednisone side effects in 32 year old male
Reported by a health professional (non-physician/pharmacist) from Tunisia on 2012-05-02
Patient: 32 year old male
Reactions: Multi-Organ Failure, Impaired Healing, Bacterial Sepsis, Aspergillosis, Febrile Neutropenia, Pyrexia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: Lymphoma
Cyclophosphamide
Indication: Lymphoma
Doxorubicin Hydrochloride
Indication: Lymphoma
Etoposide
Indication: Lymphoma
Prednisone
Indication: Lymphoma
Other drugs received by patient: Ceftazidime; Amikacin
Possible Prednisone side effects in 8 year old female
Reported by a physician from United States on 2012-05-02
Patient: 8 year old female, weighing 41.9 kg (92.2 pounds)
Reactions: Atelectasis, Blood Urea Increased, Blood Potassium Increased, Pyrexia, Disease Progression, Procedural Haemorrhage, Heart Rate Increased, Bone Marrow Failure, Pleural Effusion, Aspergillosis, Enterococcus Test Positive, Pulmonary Oedema, Lung Infiltration, Tracheitis, Blood Pressure Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 440 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-06
End date: 2012-01-10
Cytarabine
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-12-02
End date: 2012-01-30
Doxorubicin HCL
Dosage: 60 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-12-02
End date: 2011-12-02
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-06
End date: 2012-01-10
Methotrexate
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-12-02
End date: 2012-01-06
Pegaspargase
Dosage: 2500 unk, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-12-02
End date: 2012-01-04
Prednisone
Dosage: 20 mg/m2, unk
Administration route: Oral
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-12-02
End date: 2011-12-29
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-12-02
End date: 2012-01-13
Vincristine
Dosage: 1.5 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-12-02
End date: 2011-12-23
Page 1 Next >>
|